qa_id stringlengths 27 27 | qa_group_id stringlengths 28 32 | qa_family stringclasses 3
values | subtask_type stringclasses 7
values | qa_subtype stringclasses 3
values | cluster_id stringclasses 42
values | language stringclasses 1
value | split stringclasses 1
value | question stringlengths 148 1.41k | answer stringlengths 718 10.8k | claim_ids listlengths 0 8 | paper_ids listlengths 1 5 | evidence_span_ids listlengths 0 7 | association_ids listlengths 0 4 | hypothesis_ids listlengths 0 4 | record_json stringlengths 4.37k 33.7k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
QA:990ade58b0d81763071167d2 | QAG:13e597a768f07ddab018417d | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Patients expressing high levels of HIF-1α protein were also found to have increased Oct4 and Nestin expression ( p = .006 and .046, respectively)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4d18b74f29cb70a82155028f","quotes":["Patients expressing high levels of HIF-1α protein w... | [
"CLM:4d18b74f29cb70a82155028f",
"CLM:00675f01327a34449a7b47bc",
"CLM:e84625a8001191115b4fe0c9"
] | [
"PMCID:PMC4282537",
"PMCID:PMC7576728"
] | [
"SPAN:9eef6d917c1bb8a1ad199084",
"SPAN:bab627a3f16f2d33d2c01bea",
"SPAN:5933f1a1151d27b483286c96"
] | [
"ASC2:262a1f4f4ede505d66c5a651"
] | [
"HYP:DCH:d582be1d96faea9d46483249"
] | {"qa_id":"QA:990ade58b0d81763071167d2","qa_group_id":"QAG:13e597a768f07ddab018417d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Patients expressing high levels of HIF-1α protein were also found ... |
QA:997a434e6c247cf9ecfa188e | QAG:b70193b90b26f3a2076a2f29 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Levels of phosphorylation of epidermal growth factor receptor, AKT, extracellular-signal-regulated kinase 1/2, and signal transducer and activator of transcription 3 were increased in MKN45 cells after they had been co-cultured with M2 macrophages. c Amphiregulin level... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c37fc355f64bad596849d29d","quotes":["Levels of phosphorylation of epidermal growth factor receptor, AKT, extracel... | [
"CLM:c37fc355f64bad596849d29d",
"CLM:00da3643c53fd622cb15053e"
] | [
"PMCID:PMC5034006"
] | [
"SPAN:154c34b467b5c2336b4f14a3"
] | [] | [] | {"qa_id":"QA:997a434e6c247cf9ecfa188e","qa_group_id":"QAG:b70193b90b26f3a2076a2f29","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Levels of phosphorylation of epidermal growth factor receptor, AKT... |
QA:9cda0671f917a19ac2f8d0b5 | QAG:10e763aa46692cceb3690398 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "In addition, Honokiol promoted ER stress markedly inhibited HDAC3 expression via inhibition of NFκBp65/CEBPβ signaling. • HDAC3, which is a positive regulator of metastatic gastric cancer cell growth, can be significantly inhibited by Honokiol. • Opportunities for HDAC... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:77c178abaef02ff9abaf36bd","quotes":["In addition, Honokiol-induced ER stress markedly inhibited HDAC3 expression ... | [
"CLM:77c178abaef02ff9abaf36bd",
"CLM:0c54e4a5f7818005b66ea6c1"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:3305b11850fb555d98816602"
] | [] | [] | {"qa_id":"QA:9cda0671f917a19ac2f8d0b5","qa_group_id":"QAG:10e763aa46692cceb3690398","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"In addition, Honokiol promoted ER stress markedly inhibited HDAC3 ... |
QA:9db8a84d149962f6562b2dc5 | QAG:2430bcd4cbd9cb0e438fe8e2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "detected STAT3 in antral biopsies, and have demonstrated that both total STAT3 and phosphorylated STAT3 increased in intestinal-type gastric cancer compared with normal stomach"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated p... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f575b2b0931cdc6838f4fe49","quotes":["Menheniott TR, et al. detected STAT3 in antral biopsies, and have demonstrat... | [
"CLM:f575b2b0931cdc6838f4fe49",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC5400541"
] | [
"SPAN:31a8de3a1bb82fa24e750a2e"
] | [] | [] | {"qa_id":"QA:9db8a84d149962f6562b2dc5","qa_group_id":"QAG:2430bcd4cbd9cb0e438fe8e2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"detected STAT3 in antral biopsies, and have demonstrated that both... |
QA:9fd8ad4800cf7fc1abb86d6b | QAG:4460efd9465bea6c73db5c6a | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "In conclusion, TAMs in the peritoneal cavity of gastric cancer patients with peritoneal dissemination were polarized to the M2 phenotype, and M2 macrophages led to the development of peritoneal dissemination via activation of the EGFR signaling pathways"? Return the or... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4a865d2a293e7a67d193146c","quotes":["In conclusion, TAMs in the peritoneal cavity of gas... | [
"CLM:4a865d2a293e7a67d193146c",
"CLM:0985a9b6f49dc84e9bb7c0d3",
"CLM:764f03ba632e4ee3c4bd6d4a"
] | [
"PMCID:PMC5034006",
"PMCID:PMC7359096"
] | [
"SPAN:77275d6dfa8f33b33be2c619",
"SPAN:b5259dc50cc8aaf4f97ce7df"
] | [
"ASC2:715a6dc8c6eb01ea3ee8d7c7"
] | [
"HYP:DCH:e31c4dd83f361841d802af00"
] | {"qa_id":"QA:9fd8ad4800cf7fc1abb86d6b","qa_group_id":"QAG:4460efd9465bea6c73db5c6a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"In conclusion, TAMs in the peritoneal cavity of gastric cancer pat... |
QA:a09ff922b209c4aa6814d9df | QAG:039175ec5cc44f8116a0797a | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "These results indicate that IL-6-JAK2-STAT3 pathway is required for peritoneal dissemination and metastasis of gastric cancer cells promoted by CAFs in vivo , and pharmacologic blocking IL-6/JAK2/STAT3 signaling pathway in gastric cancer could reduce peritoneal dissemi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:08be5d84a853e46dce0df2a6","quotes":["These results indicate that IL-6-JAK2-STAT3 pathway... | [
"CLM:08be5d84a853e46dce0df2a6",
"CLM:04ca1189a5864792e73ecbfb",
"CLM:0d010550ec97c34813a15ea1"
] | [
"PMCID:PMC5400541",
"PMCID:PMC6627523"
] | [
"SPAN:0652c55343204dce5b8e097d",
"SPAN:2a990fe0693352750723b138"
] | [
"ASC2:ebd380557ff8a28a5f6ed034"
] | [] | {"qa_id":"QA:a09ff922b209c4aa6814d9df","qa_group_id":"QAG:039175ec5cc44f8116a0797a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"These results indicate that IL-6-JAK2-STAT3 pathway is required fo... |
QA:a47fed19d8cbc2c75091cd79 | QAG:8586a6ededdb06ec7b2ab4b0 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "BLU 9931 inhibited the growth of peritoneal dissemination of YTN 16. These studies present the first transplantable mouse gastric cancer lines"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:43c5e12f56d40dc1e007f34d","quotes":["BLU 9931 significantly inh... | [
"CLM:43c5e12f56d40dc1e007f34d",
"CLM:00da3643c53fd622cb15053e",
"CLM:36870a9dca0d16b2d1a4cca6",
"CLM:2ae4b18ed5132ab92e0d8a35"
] | [
"PMCID:PMC5980194",
"PMCID:PMC5400541",
"PMCID:PMC6899157"
] | [
"SPAN:11f3386cfa37a4d8bd43e0d5",
"SPAN:4cef4628b02d0f771197cbdb",
"SPAN:56b9ed8af47e4c0721a225f8"
] | [
"ASC2:d8dbe09dba3638e60f65a887",
"ASC2:bf57c2edff080d52c5743645"
] | [
"HYP:DCH:1a188364b529712576bdf551",
"HYP:DCH:dd8098f10b62d8dea8addd5a"
] | {"qa_id":"QA:a47fed19d8cbc2c75091cd79","qa_group_id":"QAG:8586a6ededdb06ec7b2ab4b0","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"BLU 9931 inhibited the growth of peritoneal dissemination of YTN 1... |
QA:a642e0697f2c1394cce380a6 | QAG:8153372dab896f28399c3dae | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "A total of 59 patients with advanced gastric cancer who received palliative radiotherapy during the course of the disease were included in this study, and the corresponding results showed that palliative radiotherapy improved their OS"? Return the original wording with... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0cc639ce51e27c5f997620d9","quotes":["A total of 59 patients with advanced gastric cancer who received palliative ... | [
"CLM:0cc639ce51e27c5f997620d9",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10541969"
] | [
"SPAN:64f0d20867c703057b02b7be"
] | [] | [] | {"qa_id":"QA:a642e0697f2c1394cce380a6","qa_group_id":"QAG:8153372dab896f28399c3dae","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"A total of 59 patients with advanced gastric cancer who received p... |
QA:a75cb0f4e1a7bb35a6fd0d56 | QAG:8830349b92195e70101044ce | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Gastric cancer cells promoted by IL-6 showed enhanced ability of migration compared with gastric cancer cells alone ( Supplementary Figure 1 )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ec10700d7993bd15bb55cd57","quotes":["Moreover, we determined the migration ability of gastric cancer cells induce... | [
"CLM:ec10700d7993bd15bb55cd57",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC5400541"
] | [
"SPAN:6494e4187aa5205d9e2d5623"
] | [] | [] | {"qa_id":"QA:a75cb0f4e1a7bb35a6fd0d56","qa_group_id":"QAG:8830349b92195e70101044ce","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Gastric cancer cells promoted by IL-6 showed enhanced ability of m... |
QA:a7a7ceb36fda2665fb0bf5d1 | QAG:34af31d898fd6ad0dd59d2fa | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "To interrogate the role of IL-6-JAK2-STAT3 pathway in mediating CAFs promoted migration and EMT changes of gastric cancer cells, we first explored the activation of IL-6-JAK2-STAT3 pathway in gastric cancer cells after co-culture with CAFs"? Return the original wording... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a44d3370d4e5006926ea6eed","quotes":["To interrogate the role of IL-6-JAK2-STAT3 pathway in mediating CAFs-induced... | [
"CLM:a44d3370d4e5006926ea6eed",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC5400541"
] | [
"SPAN:e29f29247da506c48242c428"
] | [] | [] | {"qa_id":"QA:a7a7ceb36fda2665fb0bf5d1","qa_group_id":"QAG:34af31d898fd6ad0dd59d2fa","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"To interrogate the role of IL-6-JAK2-STAT3 pathway in mediating CA... |
QA:a8477796cfed17f189403e88 | QAG:799ca2d6a04bb8cb1dadfa60 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "antibody, could increase T cell compartments in patients receiving a bevacizumab-based first-line therapy for metastatic colorectal cancer 9 In patients with metastatic non-small cell lung cancer, bevacizumab enhanced cytotoxic T-lymphocytes responses 10 Sunitinib is a... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:cfbbabdc5b4cc9b66459a077","quotes":["It was reported that bevacizumab, a humanized anti-VEGF monoclonal antibody,... | [
"CLM:cfbbabdc5b4cc9b66459a077",
"CLM:0985a9b6f49dc84e9bb7c0d3"
] | [
"PMCID:PMC6863181"
] | [
"SPAN:e3c0a0153c9ea8b77a82b5d1"
] | [] | [] | {"qa_id":"QA:a8477796cfed17f189403e88","qa_group_id":"QAG:799ca2d6a04bb8cb1dadfa60","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"antibody, could increase T cell compartments in patients receiving... |
QA:a8bac62571f7464a768e1a1f | QAG:15f82be40e04d1e234cd29b2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "For instance, ITGA7 was associated with cancer stemness in esophageal squamous cell carcinoma and correlates with poor prognosis in hepatocellular carcinoma"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requiremen... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:957a3961f9ecd720104f4058","quotes":["Most proteins in our signature were involved in cancer-related mechanisms. F... | [
"CLM:957a3961f9ecd720104f4058",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10284991"
] | [
"SPAN:315c8e4fc8f4eb3e2ac8b381"
] | [] | [] | {"qa_id":"QA:a8bac62571f7464a768e1a1f","qa_group_id":"QAG:15f82be40e04d1e234cd29b2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"For instance, ITGA7 was associated with cancer stemness in esophag... |
QA:a92453a3c87b1bb06b9d5a43 | QAG:390efa3e6cdde41a63d000dc | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "E Suppression of HDAC3 by Honokiol inhibited cell migration, invasion and Wnt/ß-catenin activity in gastric cancer cells To explore the involvement of Wnt/β-catenin in ER stress-reduced peritoneal cavity, Wnt/β-catenin signaling was examined in gastric cancer cells"? R... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:929f7e666695b1cf08888ab1","quotes":["E Suppression of HDAC3 by Honokiol-inhibited cell migration, invasion and Wn... | [
"CLM:929f7e666695b1cf08888ab1",
"CLM:04ca1189a5864792e73ecbfb"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:06f2c2b5aa49561bcc36024a"
] | [] | [] | {"qa_id":"QA:a92453a3c87b1bb06b9d5a43","qa_group_id":"QAG:390efa3e6cdde41a63d000dc","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"E Suppression of HDAC3 by Honokiol inhibited cell migration, invas... |
QA:aa51d5ba1bedd90eb62e2590 | QAG:856dcc05ec7f2e2c9ee1ccf6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "reported that milky spot macrophages remodeled to the M2 phenotype by gastric cancer cells promoted human peritoneal mesothelial cell injury, which led to the formation of peritoneal dissemination"? Return the original wording with paper, Claim, and Evidence Span refer... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:688725109bcb0c0ae94802ce","quotes":["Liu et al. [ 30 ] reported that milky spot macropha... | [
"CLM:688725109bcb0c0ae94802ce",
"CLM:06e549613e6d14a8f0608aa8",
"CLM:4c1346e15712b8fb41bea873"
] | [
"PMCID:PMC5034006",
"PMCID:PMC10417498"
] | [
"SPAN:3bf3670836bce677656ee04d",
"SPAN:74039e0dd1e3c8b47ae1c43d"
] | [
"ASC2:99e5f1e6c84e0be84dc6cfe8"
] | [
"HYP:DCH:6a9c92aa88ae937863e250d9"
] | {"qa_id":"QA:aa51d5ba1bedd90eb62e2590","qa_group_id":"QAG:856dcc05ec7f2e2c9ee1ccf6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"reported that milky spot macrophages remodeled to the M2 phenotype... |
QA:b154fc472310a1a99b7f5c69 | QAG:0e84c925ec4c3f6eab9ca15a | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Recently, several studies have reported that the density of M2 macrophages was associated with poor prognosis in patients with glioma, lymphoma, renal cell carcinoma, and intrahepatic cholangiocarcinoma [ 16 – 19 ]"? Return the original wording with paper, Claim, and E... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1fcf0700c69ed2cd108dfc4c","quotes":["Recently, several studies have reported that the density of M2 macrophages i... | [
"CLM:1fcf0700c69ed2cd108dfc4c",
"CLM:00da3643c53fd622cb15053e"
] | [
"PMCID:PMC5034006"
] | [
"SPAN:6856d763d71e5b60c8b8392d"
] | [] | [] | {"qa_id":"QA:b154fc472310a1a99b7f5c69","qa_group_id":"QAG:0e84c925ec4c3f6eab9ca15a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Recently, several studies have reported that the density of M2 mac... |
QA:b1830e03c9d05ed4831ff9b3 | QAG:706fb05dbfc70fe11ddc409d | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "D Gene silencing or overexpressed plasmid as indicated in SCM1 gastric cancer cells received Honokiol (40 μM) for 24 h"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passag... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:60a88933895326edf42936f0","quotes":["D Gene silencing or overexpressed plasmid as indicated in SCM1 gastric cance... | [
"CLM:60a88933895326edf42936f0",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:811b42c3852e4145612f65c4"
] | [] | [] | {"qa_id":"QA:b1830e03c9d05ed4831ff9b3","qa_group_id":"QAG:706fb05dbfc70fe11ddc409d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"D Gene silencing or overexpressed plasmid as indicated in SCM1 gas... |
QA:b5527aee85287a49c16d1fca | QAG:7b4f132c53c25813041c9636 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "pylori ‐ promoted NF‐κB‐PIEZO1‐YAP1‐CTGF axis drives gastric cancer progression and cancer‐associated fibroblast‐mediated tumour microenvironment remodelling"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requireme... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ec48ae165700d8823b14437c","quotes":["Chen B, Liu X, Yu P, et al. H. pylori ‐induced NF‐κB‐PIEZO1‐YAP1‐CTGF axis d... | [
"CLM:ec48ae165700d8823b14437c",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10659770"
] | [
"SPAN:7a19bb9edc84d6719efdb66d"
] | [] | [] | {"qa_id":"QA:b5527aee85287a49c16d1fca","qa_group_id":"QAG:7b4f132c53c25813041c9636","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"pylori ‐ promoted NF‐κB‐PIEZO1‐YAP1‐CTGF axis drives gastric cance... |
QA:b7e57cb3775b47e60f6a9bec | QAG:3badadb1825f9c4c5bbbe205 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "The results showed that the Wnt/β-catenin activity by TopFlash luciferase assay was decreased in gastric cancer cells with gene silencing of C/EBPβ and NFκB-p65, indicating that Wnt/β-catenin may be a target for NFκB-p65 or C/EBPβ"? Return the original wording with pap... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9a7598413ce670310f75a5bc","quotes":["The results showed that the Wnt/β-catenin activity by TopFlash luciferase as... | [
"CLM:9a7598413ce670310f75a5bc",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:7f3855fea05ccc41fb414a25"
] | [] | [] | {"qa_id":"QA:b7e57cb3775b47e60f6a9bec","qa_group_id":"QAG:3badadb1825f9c4c5bbbe205","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"The results showed that the Wnt/β-catenin activity by TopFlash luc... |
QA:ba3314ca203778e6bd9bb230 | QAG:8d0d23ef2f3c63c5c8816503 | provenance_qa | paper_evidence_availability | provenance_qa | G005 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC7574408? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC7574408","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC7574408"
] | [] | [] | [] | {"qa_id":"QA:ba3314ca203778e6bd9bb230","qa_group_id":"QAG:8d0d23ef2f3c63c5c8816503","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G005","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC7574408... |
QA:bf0c6cdc434f62e18f06317a | QAG:6b74e653a12eee0ec9ad3d7e | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Peritoneal metastasis was established after implantation of MKN1-Luc, N87, KATO III, MKN45-Luc, and NUGC4 in nude mice, but not formed in OCUM-1 even in NOD/SCID mice"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:2ae4b18ed5132ab92e0d8a35","quotes":["Results Peritoneal metastasis was formed after impl... | [
"CLM:2ae4b18ed5132ab92e0d8a35",
"CLM:04ca1189a5864792e73ecbfb",
"CLM:36870a9dca0d16b2d1a4cca6",
"CLM:43c5e12f56d40dc1e007f34d"
] | [
"PMCID:PMC6899157",
"PMCID:PMC5400541",
"PMCID:PMC5980194"
] | [
"SPAN:56b9ed8af47e4c0721a225f8",
"SPAN:4cef4628b02d0f771197cbdb",
"SPAN:11f3386cfa37a4d8bd43e0d5"
] | [
"ASC2:7f3dfa4927dd6af1850b8f3a",
"ASC2:bf57c2edff080d52c5743645"
] | [
"HYP:DCH:d046c0ca3b35f1ce6b4be3ea"
] | {"qa_id":"QA:bf0c6cdc434f62e18f06317a","qa_group_id":"QAG:6b74e653a12eee0ec9ad3d7e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Peritoneal metastasis was established after implantation of MKN1-L... |
QA:c29a279819ba8889309cbcca | QAG:400701e1f15bf91a36e3979f | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "In this study, we uncovered that MYH9 promoted CTNNB1 transcription promoted the peritoneal metastasis of gastric cancer cells"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supportin... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:cfd33badf96604b68792bd69","quotes":["In this study, we uncovered that MYH9-induced CTNNB1 transcription promoted ... | [
"CLM:cfd33badf96604b68792bd69",
"CLM:04ca1189a5864792e73ecbfb"
] | [
"PMCID:PMC7359096"
] | [
"SPAN:b5259dc50cc8aaf4f97ce7df"
] | [] | [] | {"qa_id":"QA:c29a279819ba8889309cbcca","qa_group_id":"QAG:400701e1f15bf91a36e3979f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"In this study, we uncovered that MYH9 promoted CTNNB1 transcriptio... |
QA:c37f4d3f56ea10dd68ebaecc | QAG:51daabbdf3cbcd01b9dd91af | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "The level of HIF-1α was increased in GC peritonea with PM, suggesting that the metastatic peritoneal microenvironment in gastric cancer is indeed hypoxic (Fig. 1 a)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance re... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e84625a8001191115b4fe0c9","quotes":["The level of HIF-1α was significantly increased in GC peritonea with PM, sug... | [
"CLM:e84625a8001191115b4fe0c9",
"CLM:00da3643c53fd622cb15053e"
] | [
"PMCID:PMC7576728"
] | [
"SPAN:5933f1a1151d27b483286c96"
] | [] | [] | {"qa_id":"QA:c37f4d3f56ea10dd68ebaecc","qa_group_id":"QAG:51daabbdf3cbcd01b9dd91af","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"The level of HIF-1α was increased in GC peritonea with PM, suggest... |
QA:c428cd9e9cf6c0d50cfda8b6 | QAG:996b27cc4a4479bbeab2b0ad | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "The transfer of YN968D1-treated T cells achieved better tumor control compared to DMSO-treated T cells or control in both peritoneal dissemination and subcutaneous gastric cancer mouse models"? Return the original wording with paper, Claim, and Evidence Span references... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:fb0451299bed015241296e71","quotes":["The transfer of YN968D1-treated T cells achieved be... | [
"CLM:fb0451299bed015241296e71",
"CLM:00da3643c53fd622cb15053e",
"CLM:688725109bcb0c0ae94802ce"
] | [
"PMCID:PMC6863181",
"PMCID:PMC5034006"
] | [
"SPAN:29f2079ba6d29aaa7dc5c32b",
"SPAN:3bf3670836bce677656ee04d"
] | [
"ASC2:7b9bca7e5d431da399ea6b9d"
] | [
"HYP:DCH:fa4d356524390aff7e2357e3"
] | {"qa_id":"QA:c428cd9e9cf6c0d50cfda8b6","qa_group_id":"QAG:996b27cc4a4479bbeab2b0ad","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"The transfer of YN968D1-treated T cells achieved better tumor cont... |
QA:c4988421513b6a08a6b83716 | QAG:02a050f239461a68e00879aa | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Furthermore, the GCSPC population expanded in primary gastric cancer cells under hypoxic condition in vitro, and hypoxic GCSPCs showed enhanced self-renewal ability, but decreased differentiation capacity, mediated by HIF-1α"? Return the original wording with paper, Cl... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9eee6a5f87b2e586398414bd","quotes":["Furthermore, the GCSPC population expanded in primary gastric cancer cells u... | [
"CLM:9eee6a5f87b2e586398414bd",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC4282537"
] | [
"SPAN:15e32e0258f204154aa81767"
] | [] | [] | {"qa_id":"QA:c4988421513b6a08a6b83716","qa_group_id":"QAG:02a050f239461a68e00879aa","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Furthermore, the GCSPC population expanded in primary gastric canc... |
QA:c588e6f2741794b6481b268e | QAG:3ba99444d66201fbe74506e1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Conditioned medium from diffuse-type gastric cancer cells promoted the CXCR2 expression in BM-MCs ( p <0.01)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with pap... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:94728bf50763f5e92e1acd4a","quotes":["Conditioned medium from diffuse-type gastric cancer cells significantly stim... | [
"CLM:94728bf50763f5e92e1acd4a",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC5456266"
] | [
"SPAN:8f6a1fb4e99abf0562f9aac9"
] | [] | [] | {"qa_id":"QA:c588e6f2741794b6481b268e","qa_group_id":"QAG:3ba99444d66201fbe74506e1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Conditioned medium from diffuse-type gastric cancer cells promoted... |
QA:c5c53807cc0b176ac123d524 | QAG:b2fcc7ec5eab731fef832d5d | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "We also ruled out the involvement of HDAC1/2 in the Honokiol promoted effects on gastric cancer cells (Figs"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with pape... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c13e791c29a9c06d1176cded","quotes":["We also ruled out the involvement of HDAC1/2 in the Honokiol-induced effects... | [
"CLM:c13e791c29a9c06d1176cded",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:7e10c33d2fd3f4ebdefc58c1"
] | [] | [] | {"qa_id":"QA:c5c53807cc0b176ac123d524","qa_group_id":"QAG:b2fcc7ec5eab731fef832d5d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"We also ruled out the involvement of HDAC1/2 in the Honokiol promo... |
QA:c5dda10fc617d9904a5ae43c | QAG:3b736bd73f9c5c37c5f0ff34 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "ONECUT2 Upregulation was associated with CpG Hypomethylation at Promoter-Proximal DNA in Gastric Cancer and Triggers ACSL5"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting pa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:45734a2780755169d544d4cb","quotes":["Oncol Lett (2020) 20(6):328. 46. Seo E-H, Kim H-J, Kim J-H, Lim B, Park J-L,... | [
"CLM:45734a2780755169d544d4cb",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC9280277"
] | [
"SPAN:41ed2cacb1bfab8ffc1717c6"
] | [] | [] | {"qa_id":"QA:c5dda10fc617d9904a5ae43c","qa_group_id":"QAG:3b736bd73f9c5c37c5f0ff34","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"ONECUT2 Upregulation was associated with CpG Hypomethylation at Pr... |
QA:c6b802208ac34dab955218da | QAG:4d5ee7d64e11ecdfdea724e4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Figure 3 Hypoxia increased gastric cancer stem/progenitor cell (GCSPC) self-renew, but reduced GCSPC differentiation"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:52b13f8fdda66323a904d0fb","quotes":["Figure 3 Hypoxia enhanced gastric cancer stem/progenitor cell (GCSPC) self-r... | [
"CLM:52b13f8fdda66323a904d0fb",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC4282537"
] | [
"SPAN:12c17677ec9498d99febe825"
] | [] | [] | {"qa_id":"QA:c6b802208ac34dab955218da","qa_group_id":"QAG:4d5ee7d64e11ecdfdea724e4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Figure 3 Hypoxia increased gastric cancer stem/progenitor cell (GC... |
QA:c711efe9b99d704916d88241 | QAG:c2dabd78a76998f38ba6235f | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "We show that CAFs derived-IL-6 promoted the migration and EMT of gastric cancer cells via the activation of JAK2-STAT3 pathway, and blocking this pathway with IL-6 neutralizing antibody or JAK2 specific inhibitor AG490 impaired gastric cancer metastasis induced by CAFs... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f4462c3e690d02f810542bd2","quotes":["We show that CAFs derived-IL-6 promoted the migration and EMT of gastric can... | [
"CLM:f4462c3e690d02f810542bd2",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC5400541"
] | [
"SPAN:ababd96675bf5abe962e4cf0"
] | [] | [] | {"qa_id":"QA:c711efe9b99d704916d88241","qa_group_id":"QAG:c2dabd78a76998f38ba6235f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"We show that CAFs derived-IL-6 promoted the migration and EMT of g... |
QA:ccd85d5a03e45fd533c41ba9 | QAG:3218ed0f9021384b42c19381 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Compared with chemotherapy, first-line ICIs combined with chemotherapy prolonged PFS but did not improve overall survival in patients with HER-2-negative advanced gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:542f3077cd8d7661d17ae415","quotes":["Compared with chemotherapy, first-line ICIs combined with chemotherapy prolo... | [
"CLM:542f3077cd8d7661d17ae415",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10541969"
] | [
"SPAN:41e690bbec86007a555502a5"
] | [] | [] | {"qa_id":"QA:ccd85d5a03e45fd533c41ba9","qa_group_id":"QAG:3218ed0f9021384b42c19381","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Compared with chemotherapy, first-line ICIs combined with chemothe... |
QA:cd58cd8a220de74724bd871a | QAG:f7cdefccdfc333ffa1656d2b | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "In our model, co-injection of MLCs also increased tumorigenicity of gastric cancer cells, but probably through a different mechanism"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact sup... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b6770e28d9c417160f0a22ec","quotes":["In our model, co-injection of MLCs also enhanced tumorigenicity of gastric c... | [
"CLM:b6770e28d9c417160f0a22ec",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC3897715"
] | [
"SPAN:83a5b6569247b5773e158563"
] | [] | [] | {"qa_id":"QA:cd58cd8a220de74724bd871a","qa_group_id":"QAG:f7cdefccdfc333ffa1656d2b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"In our model, co-injection of MLCs also increased tumorigenicity o... |
QA:cff5bd67c34284593c385c33 | QAG:ed2572f7994f74195a63f240 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "reported that milky spot macrophages remodeled to the M2 phenotype by gastric cancer cells promoted human peritoneal mesothelial cell injury, which contributed to the formation of peritoneal dissemination"? Return the original wording with paper, Claim, and Evidence Sp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:00675f01327a34449a7b47bc","quotes":["Liu et al. [ 30 ] reported that milky spot macrophages remodeled to the M2 p... | [
"CLM:00675f01327a34449a7b47bc",
"CLM:00da3643c53fd622cb15053e"
] | [
"PMCID:PMC5034006"
] | [
"SPAN:3bf3670836bce677656ee04d"
] | [] | [] | {"qa_id":"QA:cff5bd67c34284593c385c33","qa_group_id":"QAG:ed2572f7994f74195a63f240","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"reported that milky spot macrophages remodeled to the M2 phenotype... |
QA:d16dfcc3c94442337cb7df9f | QAG:fd7ba4aaac8793a45a376fd8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Gastric cancer is one of the most common malignant tumors in the gastrointestinal system and was associated with a pessimistic prognosis 1 – 3"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f64258fffc4fcbf55990ba27","quotes":["Gastric cancer is one of the most common malignant tumors in the gastrointes... | [
"CLM:f64258fffc4fcbf55990ba27",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC4282537"
] | [
"SPAN:3da47a264d5e030e1d79e90b"
] | [] | [] | {"qa_id":"QA:d16dfcc3c94442337cb7df9f","qa_group_id":"QAG:fd7ba4aaac8793a45a376fd8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Gastric cancer is one of the most common malignant tumors in the g... |
QA:d18079690863526a046366e0 | QAG:c80c83094fbcc0ad55e47013 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Two hundred fifty (250) gastric cancer patients treated at the National Cancer Center Hospital East (NCCHE) or the National Cancer Center Hospital (NCCH) from May 2013 to Feb 2017 were enrolled in this study"? Return the original wording with paper, Claim, and Evidence... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0cef0d76367825f2050e58cd","quotes":["Two hundred fifty (250) gastric cancer patients treated at the National Canc... | [
"CLM:0cef0d76367825f2050e58cd",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC6627523"
] | [
"SPAN:8da3d6fe701ec9346838cf0d"
] | [] | [] | {"qa_id":"QA:d18079690863526a046366e0","qa_group_id":"QAG:c80c83094fbcc0ad55e47013","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Two hundred fifty (250) gastric cancer patients treated at the Nat... |
QA:d1883024405b3fe618500ce5 | QAG:d119bd5c2d88964a89f4dbbf | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "The findings of this PSM study showed that first-line treatment with chemotherapy combined with ICIs improved PFS in patients with HER-2 negative advanced gastric cancer; however, there was no significant improvement in OS, and the side effects were tolerable"? Return ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c6d922640fd4af554878bc11","quotes":["5. The findings of this PSM study showed that first-line treatment with chem... | [
"CLM:c6d922640fd4af554878bc11",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10541969"
] | [
"SPAN:f1f1df0c468c19214e443c74"
] | [] | [] | {"qa_id":"QA:d1883024405b3fe618500ce5","qa_group_id":"QAG:d119bd5c2d88964a89f4dbbf","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"The findings of this PSM study showed that first-line treatment wi... |
QA:d4cc7ec34498bdde2831ec50 | QAG:b767c0c56b5680fb1ef37335 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "As shown in Figure 1A , IL-6 levels in the serum of gastric cancer patients were increased in comparison with healthy volunteers"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact support... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f036e00d02074afb2fef3164","quotes":["As shown in Figure 1A , IL-6 levels in the serum of gastric cancer patients ... | [
"CLM:f036e00d02074afb2fef3164",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC5400541"
] | [
"SPAN:431b93395b8ff099d727906f"
] | [] | [] | {"qa_id":"QA:d4cc7ec34498bdde2831ec50","qa_group_id":"QAG:b767c0c56b5680fb1ef37335","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"As shown in Figure 1A , IL-6 levels in the serum of gastric cancer... |
QA:d6923d5d63a1d59fcf01514f | QAG:6b58a58a5543527465fccbbf | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "The study found that biological functions of plasma exosome proteins among AGC patients with different metastatic modes were distinct, in which ILK1 and CD14 was correlated with organ-specific metastasis and participated in regulating malignant behaviors in gastric can... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:5ea3a38a223ee26da7136eb8","quotes":["The study found that biological functions of plasma exosome proteins among A... | [
"CLM:5ea3a38a223ee26da7136eb8",
"CLM:06e549613e6d14a8f0608aa8"
] | [
"PMCID:PMC10417498"
] | [
"SPAN:7b364acde05e3e54e0d4ef62"
] | [] | [] | {"qa_id":"QA:d6923d5d63a1d59fcf01514f","qa_group_id":"QAG:6b58a58a5543527465fccbbf","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"The study found that biological functions of plasma exosome protei... |
QA:d70836efa9cff18bf6d73b10 | QAG:6f6ff816902bd16f6068ad0f | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Since malignant effusions represent an immune inhibited niche, we investigated whether peritoneal involvement with or without ascites is a poor prognostic factor in patients with dMMR/MSI-H metastatic colorectal cancer (mCRC) and gastric cancer (mGC) receiving ICIs"? R... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:2415939cd09433831ee4aea2","quotes":["Since malignant effusions represent an immune-suppr... | [
"CLM:2415939cd09433831ee4aea2",
"CLM:00da3643c53fd622cb15053e",
"CLM:3f001575dc5ba7f2bd6df54b"
] | [
"PMCID:PMC8811606",
"PMCID:PMC10255232"
] | [
"SPAN:bbf9c521a0285ca0a841105c",
"SPAN:0e6be7c879db295a68821686"
] | [
"ASC2:e7817513984409b2c5a423ce"
] | [
"HYP:DCH:2c516a8bbd16244a18df4129"
] | {"qa_id":"QA:d70836efa9cff18bf6d73b10","qa_group_id":"QAG:6f6ff816902bd16f6068ad0f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Since malignant effusions represent an immune inhibited niche, we ... |
QA:d9c2bf6c19f369885a0a3a00 | QAG:bde9c781d93a7dca39b26445 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Protein tyrosine phosphorylation was increased or altered in DGC cell lines compared with that in other gastric cancer cell lines"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact suppor... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:2e8ebef195ff909cd998ca5f","quotes":["Protein tyrosine phosphorylation was significantly enhanced or altered in DG... | [
"CLM:2e8ebef195ff909cd998ca5f",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC4317844"
] | [
"SPAN:ccba9bf23cce2689eee21d01"
] | [] | [] | {"qa_id":"QA:d9c2bf6c19f369885a0a3a00","qa_group_id":"QAG:bde9c781d93a7dca39b26445","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Protein tyrosine phosphorylation was increased or altered in DGC c... |
QA:dbcd20786cafd43e352bfbf0 | QAG:6a91d171428a6f4acf6f7f90 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "This study is for the first time to elucidate the role of Honokiol promoted changes in HDAC3 (Y298) site and C/EBPβ, NFκB, on EMT and on peritoneal dissemination in gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrate... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d8176904652e78ed34aacb7f","quotes":["This study is for the first time to elucidate the role of Honokiol-induced c... | [
"CLM:d8176904652e78ed34aacb7f",
"CLM:04ca1189a5864792e73ecbfb"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:463b6f5376e862a0198cda4b"
] | [] | [] | {"qa_id":"QA:dbcd20786cafd43e352bfbf0","qa_group_id":"QAG:6a91d171428a6f4acf6f7f90","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"This study is for the first time to elucidate the role of Honokiol... |
QA:dd25612940d76a0817652b8f | QAG:a4dd0b66f32db6a9e6fe7b85 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Patients with positive HIF-1α expression were also found to have increased Oct4 and Nestin expression (Table 1 ), indicating that hypoxia-regulated GCSPC maintenance may be involved in the GCPD process"? Return the original wording with paper, Claim, and Evidence Span ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e258debb64459ebf6e97482e","quotes":["Patients with positive HIF-1α expression were also found to have elevated Oc... | [
"CLM:e258debb64459ebf6e97482e",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC4282537"
] | [
"SPAN:0fb71f8a4c85c9254a2e5d02",
"SPAN:a6aed13f128d5b2c829ba3bb"
] | [] | [] | {"qa_id":"QA:dd25612940d76a0817652b8f","qa_group_id":"QAG:a4dd0b66f32db6a9e6fe7b85","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Patients with positive HIF-1α expression were also found to have i... |
QA:ded3b79159c0531fb18dade1 | QAG:645cff92ee8b61211121ccf8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Clinically, compared to normal adjacent tissues, esophageal tumor samples showed an up-regulation of SOX4, EZH2, and HDAC3 in which the EZH2 expression was increased in metastatic ESCC tissues (Koumangoye et al. 2015 )"? Return the original wording with paper, Claim, a... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c733d4b259dbaa2953f08a3d","quotes":["Clinically, compared to normal adjacent tissues, esophageal tumor samples sh... | [
"CLM:c733d4b259dbaa2953f08a3d",
"CLM:00da3643c53fd622cb15053e"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:7548a4f13d04839a0ab22b4a"
] | [] | [] | {"qa_id":"QA:ded3b79159c0531fb18dade1","qa_group_id":"QAG:645cff92ee8b61211121ccf8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Clinically, compared to normal adjacent tissues, esophageal tumor ... |
QA:e2fefdb51c08dadcb5ad98a4 | QAG:da2e0aaf513c988a2e3769f6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Figure 3 Hypoxia enhanced gastric cancer stem/progenitor cell (GCSPC) self-renew, but decreased GCSPC differentiation"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:421ba50a06782ab9113daece","quotes":["Figure 3 Hypoxia enhanced gastric cancer stem/progenitor cell (GCSPC) self-r... | [
"CLM:421ba50a06782ab9113daece",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC4282537"
] | [
"SPAN:12c17677ec9498d99febe825"
] | [] | [] | {"qa_id":"QA:e2fefdb51c08dadcb5ad98a4","qa_group_id":"QAG:da2e0aaf513c988a2e3769f6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Figure 3 Hypoxia enhanced gastric cancer stem/progenitor cell (GCS... |
QA:e818a21cb14ed00a3ad4f0c5 | QAG:1b0c6cd3cc4a47ef218fd19f | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "It was reported that bevacizumab, a humanized anti-VEGF monoclonal antibody, could increase T cell compartments in patients receiving a bevacizumab-based first-line therapy for metastatic colorectal cancer 9 In patients with metastatic non-small cell lung cancer, bevac... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ee77724112b41bf00c2624df","quotes":["It was reported that bevacizumab, a humanized anti-VEGF monoclonal antibody,... | [
"CLM:ee77724112b41bf00c2624df",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC6863181"
] | [
"SPAN:e3c0a0153c9ea8b77a82b5d1"
] | [] | [] | {"qa_id":"QA:e818a21cb14ed00a3ad4f0c5","qa_group_id":"QAG:1b0c6cd3cc4a47ef218fd19f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"It was reported that bevacizumab, a humanized anti-VEGF monoclonal... |
QA:e8c6272746a5812976cdad61 | QAG:a0ae54f3531e3fe488c64856 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "ILK1 and CD14 was correlated with organ-specific metastasis and participated in regulating biological behavior sin gastric cancer cells"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:2733f3122bd7416fc386e2a5","quotes":["ILK1 and CD14 were correlated with organ-specific metastasis and participate... | [
"CLM:2733f3122bd7416fc386e2a5",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10417498"
] | [
"SPAN:5944ff25838ec50a12343d1f"
] | [] | [] | {"qa_id":"QA:e8c6272746a5812976cdad61","qa_group_id":"QAG:a0ae54f3531e3fe488c64856","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"ILK1 and CD14 was correlated with organ-specific metastasis and pa... |
QA:ef4724f3e3f43c8356ef9819 | QAG:489ea9650056a6bad55c092e | provenance_qa | paper_evidence_availability | provenance_qa | G005 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC10725580? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiabl... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC10725580","verdict":"no_released_traceable_claim","reason":"No... | [] | [
"PMCID:PMC10725580"
] | [] | [] | [] | {"qa_id":"QA:ef4724f3e3f43c8356ef9819","qa_group_id":"QAG:489ea9650056a6bad55c092e","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G005","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC1072558... |
QA:f18781419c8aab6fd5c9df9d | QAG:51b6dad232a9ceda5463f314 | provenance_qa | paper_evidence_availability | provenance_qa | G005 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9830517? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9830517","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9830517"
] | [] | [] | [] | {"qa_id":"QA:f18781419c8aab6fd5c9df9d","qa_group_id":"QAG:51b6dad232a9ceda5463f314","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G005","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9830517... |
QA:f73735247a5c15318d22b4a7 | QAG:a6f44793e2c4b76e2ee3bc81 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "We previously established stomach cancer cell lines from N ‐methyl‐ N ‐nitrosourea (MNU) promoted glandular stomach carcinoma in BALB/c and BDF1 mice, which were non‐tumorigenic upon transplantation"? Return the original wording with paper, Claim, and Evidence Span ref... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d57f56058f6767a95aeae310","quotes":["We previously established stomach cancer cell lines from N ‐methyl‐ N ‐nitro... | [
"CLM:d57f56058f6767a95aeae310",
"CLM:00da3643c53fd622cb15053e"
] | [
"PMCID:PMC5980194"
] | [
"SPAN:e4be89246cbedf3f33ac0647"
] | [] | [] | {"qa_id":"QA:f73735247a5c15318d22b4a7","qa_group_id":"QAG:a6f44793e2c4b76e2ee3bc81","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"We previously established stomach cancer cell lines from N ‐methyl... |
QA:f747f3fc3e807f712181ddb5 | QAG:351546a321cb7fc9c1175bea | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Upregulation of the expression of ASNS was associated with poor prognosis in patients with colorectal cancer ( 21 ), hepatocellular carcinoma ( 22 ) and malignant gliomas ( 23 ), suggesting a prominent role in cancer progression"? Return the original wording with paper... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:faf34b5b8654e1c5d0694162","quotes":["Upregulation of the expression of ASNS is associated with poor prognosis in ... | [
"CLM:faf34b5b8654e1c5d0694162",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10472050"
] | [
"SPAN:1fd6f2446fff81b4a52bdfa9"
] | [] | [] | {"qa_id":"QA:f747f3fc3e807f712181ddb5","qa_group_id":"QAG:351546a321cb7fc9c1175bea","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Upregulation of the expression of ASNS was associated with poor pr... |
QA:f84450dad5c1fe9a4051322f | QAG:687d889ae013bb5d25e269a7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "C SCM1 or AGS gastric cancer cells received Honokiol (40 μM) or melatonin (MT; 100 mM) for 24 h, and transiently transfected with NFκB plasmid or C/EBPβ plasmid for HDAC3 activity"? Return the original wording with paper, Claim, and Evidence Span references.
Integrate... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d7651e3e5718d67353aa6e13","quotes":["C SCM1 or AGS gastric cancer cells were treated with Honokiol (40 μM) or mel... | [
"CLM:d7651e3e5718d67353aa6e13",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:8cecdba2bff780e479cfa65d"
] | [] | [] | {"qa_id":"QA:f84450dad5c1fe9a4051322f","qa_group_id":"QAG:687d889ae013bb5d25e269a7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"C SCM1 or AGS gastric cancer cells received Honokiol (40 μM) or me... |
QA:f9e7ef50fead5d023b9484b4 | QAG:f0a4c6d9608ed6a675d960c5 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "Moreover, we determined the migration ability of gastric cancer cells promoted by exogenous IL-6. Gastric cancer cells stimulated by IL-6 showed enhanced ability of migration compared with gastric cancer cells alone ( Supplementary Figure 1 )"? Return the original word... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1971b4b6e8759d104bd15299","quotes":["Moreover, we determined the migration ability of gastric cancer cells induce... | [
"CLM:1971b4b6e8759d104bd15299",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC5400541"
] | [
"SPAN:6494e4187aa5205d9e2d5623"
] | [] | [] | {"qa_id":"QA:f9e7ef50fead5d023b9484b4","qa_group_id":"QAG:f0a4c6d9608ed6a675d960c5","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"Moreover, we determined the migration ability of gastric cancer ce... |
QA:f9fd8fa0f7e4e9d0e0564d01 | QAG:5739ab82209efa30296a7103 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "In the present study, by establishing CD14- and ILK1-overexpressing gastric cancer cell models, the size of colonies was increased more than in control cells, which suggested CD14 and ILK1 could promote outgrowth of metastasis in gastric cancer"? Return the original wo... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7baec1db12ede500d73811c1","quotes":["In the present study, by establishing CD14- and ILK1-overexpressing gastric ... | [
"CLM:7baec1db12ede500d73811c1",
"CLM:04ca1189a5864792e73ecbfb"
] | [
"PMCID:PMC10417498"
] | [
"SPAN:6f651c520bc7af2c8b709d6a"
] | [] | [] | {"qa_id":"QA:f9fd8fa0f7e4e9d0e0564d01","qa_group_id":"QAG:5739ab82209efa30296a7103","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"In the present study, by establishing CD14- and ILK1-overexpressin... |
QA:fa91ba037c84175a93cb0abd | QAG:b247d0cd9845116d549aa00d | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "The remaining 17 cases received cell-free and concentrated ascites reinfusion therapy (CART) for retaining ascites fluid caused by peritoneal dissemination of gastric cancer during the period and were designated as CART cases"? Return the original wording with paper, C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4f89fcee45b8721e5718c893","quotes":["The remaining 17 cases received cell-free and conce... | [
"CLM:4f89fcee45b8721e5718c893",
"CLM:00da3643c53fd622cb15053e",
"CLM:764f03ba632e4ee3c4bd6d4a"
] | [
"PMCID:PMC6627523",
"PMCID:PMC7359096"
] | [
"SPAN:e912db881156aff4bb951058",
"SPAN:b5259dc50cc8aaf4f97ce7df"
] | [
"ASC2:4b74f80faeac0b938aef64b7"
] | [
"HYP:DCH:ee90348adc9d6bc674a8d44d"
] | {"qa_id":"QA:fa91ba037c84175a93cb0abd","qa_group_id":"QAG:b247d0cd9845116d549aa00d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"The remaining 17 cases received cell-free and concentrated ascites... |
QA:fbf7504459f956ae2e8860f5 | QAG:640ce5787fc111c70c7027d5 | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "A total of 59 patients with advanced gastric cancer who received palliative radiotherapy during the course of the disease were included in this study, and the corresponding results showed that palliative radiotherapy improved their OS"? Return the original wording with... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:685f91a9d96577ca9879f999","quotes":["A total of 59 patients with advanced gastric cancer who received palliative ... | [
"CLM:685f91a9d96577ca9879f999",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10541969"
] | [
"SPAN:64f0d20867c703057b02b7be"
] | [] | [] | {"qa_id":"QA:fbf7504459f956ae2e8860f5","qa_group_id":"QAG:640ce5787fc111c70c7027d5","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"A total of 59 patients with advanced gastric cancer who received p... |
QA:ff4d71e69c29794970e88ba0 | QAG:4ddaecf5c52288a469b01d3d | provenance_qa | exact_evidence_retrieval | provenance_qa | G005 | en | train | Which exact source passage supports the statement "8 Suppression of HDAC3 by Honokiol inhibited cell migration and invasion in gastric cancer cells"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, a... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c27ba2c19053f12d38c30bf6","quotes":["Fig. 8 Suppression of HDAC3 by Honokiol-inhibited cell migration and invasio... | [
"CLM:c27ba2c19053f12d38c30bf6",
"CLM:00675f01327a34449a7b47bc"
] | [
"PMCID:PMC10547655"
] | [
"SPAN:586b0fa3187375cf208ec6f8"
] | [] | [] | {"qa_id":"QA:ff4d71e69c29794970e88ba0","qa_group_id":"QAG:4ddaecf5c52288a469b01d3d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G005","question":"Which exact source passage supports the statement \"8 Suppression of HDAC3 by Honokiol inhibited cell migration and in... |
QA:0235ed616f2275b85d178a29 | QAG:8c3809d93465311897073681 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Conclusion NIT in patients with early-stage dMMR CRC was associated with a high response rate, low primary resistance to immunotherapy and cancer recurrence rate, and an excellent safety profile"? Return the original wording with paper, Claim, and Evidence Span referen... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:115f68cc5dc19ffb337a32ea","quotes":["Conclusion NIT in patients with early-stage dMMR CRC is associated with a hi... | [
"CLM:115f68cc5dc19ffb337a32ea",
"CLM:439debb91a7c2319411d2844"
] | [
"PMID:37595183"
] | [
"SPAN:9a3d1e3f65375eb4bf00d997"
] | [] | [] | {"qa_id":"QA:0235ed616f2275b85d178a29","qa_group_id":"QAG:8c3809d93465311897073681","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Conclusion NIT in patients with early-stage dMMR CRC was associate... |
QA:059551ed074ca052dbb5d5b2 | QAG:f4f8c03b7b02350f62ab0fba | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "We observed that neoadjuvant administration of anti-PD-1 in patients with advanced MSI-H/dMMR colorectal cancer was associated with acceptable immediate adverse events"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1ba3760c1a1556023e343cb4","quotes":["We observed that neoadjuva... | [
"CLM:1ba3760c1a1556023e343cb4",
"CLM:439debb91a7c2319411d2844",
"CLM:02b542ecdd30313379778da4",
"CLM:5ac06993f5304cdf6a1e85dd"
] | [
"PMCID:PMC6984585",
"PMID:36030556",
"PMCID:PMC10142806"
] | [
"SPAN:75517d82064dd16484458eaf",
"SPAN:cd71edbc4e9aefd0a762b6b4",
"SPAN:172526e920fbbabec14bf918"
] | [
"ASC2:c36c073ab9bfb0234e9380d7",
"ASC2:af0d17a0fb0c9f4e56b55534"
] | [
"HYP:DCH:02e65d8fc1d245c5571227da",
"HYP:DCH:724c0a6193cab97b64d4f2d4"
] | {"qa_id":"QA:059551ed074ca052dbb5d5b2","qa_group_id":"QAG:f4f8c03b7b02350f62ab0fba","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"We observed that neoadjuvant administration of anti-PD-1 in patien... |
QA:05df37fe18f8aa9fd88ecde0 | QAG:66cb06c1b682164d6283bccd | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "IL-1β promoted elevation of CRC tumor volume (745.74 ± 188.34) and weight (0.73 ± 0.16) was greatly attenuated by diacerein (619.59 ± 127.03, 0.49 ± 0.09) or nivolumab (540.47 ± 90.92, 0.49 ± 0.10, P < 0.05), and treatment with both drugs led to the greatest attenuatio... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0f2d72d7fd0c69ae69573dd4","quotes":["IL-1β-induced elevation of CRC tumor volume (745.74 ± 188.34) and weight (0.... | [
"CLM:0f2d72d7fd0c69ae69573dd4",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC10142806"
] | [
"SPAN:af0bb365db8164a231b9419e"
] | [] | [] | {"qa_id":"QA:05df37fe18f8aa9fd88ecde0","qa_group_id":"QAG:66cb06c1b682164d6283bccd","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"IL-1β promoted elevation of CRC tumor volume (745.74 ± 188.34) and... |
QA:0ae774fe0311a62b6ad99476 | QAG:e57b70168c4ce1324790ade9 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Indeed, in the aforementioned NICHE study, restricted to colon cancer patients, neoadjuvant immunotherapy with two cycles of nivolumab plus one cycle of ipilimumab ± celecoxib before tumor resection led to a 30% pathologic response among the 30 patients included in the... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b540b1bdb1e42c51b71f704e","quotes":["Indeed, in the aforementioned NICHE study, restricted to colon cancer patien... | [
"CLM:b540b1bdb1e42c51b71f704e",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC9496787"
] | [
"SPAN:1b3a29f8bc94016c1c91f745"
] | [] | [] | {"qa_id":"QA:0ae774fe0311a62b6ad99476","qa_group_id":"QAG:e57b70168c4ce1324790ade9","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Indeed, in the aforementioned NICHE study, restricted to colon can... |
QA:0c55d91f69cc3b0a49732324 | QAG:506352151ba46ffb2bcb5542 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "0% (12/20) ( 10 ), and 17 patients with dMMR/MSI⁃H LACRC included in PICC study received single-agent nIT with treprizumab (200mg, q3w) for 6 cycles (18 weeks), and the pCR rate was 64.7% (11/17) ( 11 )"? Return the original wording with paper, Claim, and Evidence Span... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:fa9cba6c65853067e4efc5e2","quotes":["Further comparative analysis indicated that 20 patients with dMMR stage I ~ ... | [
"CLM:fa9cba6c65853067e4efc5e2",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC9359076"
] | [
"SPAN:bd98a0239146706542ac5038"
] | [] | [] | {"qa_id":"QA:0c55d91f69cc3b0a49732324","qa_group_id":"QAG:506352151ba46ffb2bcb5542","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"0% (12/20) ( 10 ), and 17 patients with dMMR/MSI⁃H LACRC included ... |
QA:0d13460f6be092e8aa4fbffd | QAG:f41a7afd05eb02fb5181f1f4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Conclusions For patients with dMMR/MSI-H locally advanced rectal cancer who achieved cCR during anti-PD-1 immunotherapy, adopting immunotherapy as curative-intent treatment might be an alternative option"? Return the original wording with paper, Claim, and Evidence Spa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:02b542ecdd30313379778da4","quotes":["Conclusions For patients with dMMR/MSI-H locally ad... | [
"CLM:02b542ecdd30313379778da4",
"CLM:439debb91a7c2319411d2844",
"CLM:a17b5d1a2a868798b4e8707b",
"CLM:eba667832912dfd0e18bf356",
"CLM:5ac06993f5304cdf6a1e85dd"
] | [
"PMID:36030556",
"PMCID:PMC10142806",
"PMCID:PMC9496787"
] | [
"SPAN:cd71edbc4e9aefd0a762b6b4",
"SPAN:69049fb9150b33478404d849",
"SPAN:ee3f6b8a83da99edce046e7f",
"SPAN:172526e920fbbabec14bf918"
] | [
"ASC2:15aca1021efc59c7b8889c00",
"ASC2:af0d17a0fb0c9f4e56b55534"
] | [
"HYP:DCH:84aa0772602265ef40e54d00"
] | {"qa_id":"QA:0d13460f6be092e8aa4fbffd","qa_group_id":"QAG:f41a7afd05eb02fb5181f1f4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Conclusions For patients with dMMR/MSI-H locally advanced rectal c... |
QA:0d51a92025317c68d17003fc | QAG:8d7db27136df2df6c000d3ff | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "(3) no patients received neoadjuvant therapy before operation; (4) no patients received anti-PD-1/PD-L1 therapy"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3aa8d45476982b74a03ce6ca","quotes":["The inclusion criteria were as follows: (1) all patients were diagnosed with... | [
"CLM:3aa8d45476982b74a03ce6ca",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC8505364"
] | [
"SPAN:ac832faed8054015ee2920ef"
] | [] | [] | {"qa_id":"QA:0d51a92025317c68d17003fc","qa_group_id":"QAG:8d7db27136df2df6c000d3ff","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"(3) no patients received neoadjuvant therapy before operation; (4)... |
QA:0ebcc876b8e102358f976d3f | QAG:556a849bead936a4b6a3e30c | provenance_qa | paper_evidence_availability | provenance_qa | G007 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8144732? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC8144732","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC8144732"
] | [] | [] | [] | {"qa_id":"QA:0ebcc876b8e102358f976d3f","qa_group_id":"QAG:556a849bead936a4b6a3e30c","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G007","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8144732... |
QA:0fb6f7dbd6d9bc1d15f97d1f | QAG:4d1e18aed4cb8360725800ce | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "An improved prognosis for CRC patients was associated with the activation of the STING signalling system"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b91aa416de96369c004fbb4f","quotes":["An improved prognosis for CRC patients is associated with the activation of ... | [
"CLM:b91aa416de96369c004fbb4f",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC9818394"
] | [
"SPAN:472ae4ba410d88890cca88e4"
] | [] | [] | {"qa_id":"QA:0fb6f7dbd6d9bc1d15f97d1f","qa_group_id":"QAG:4d1e18aed4cb8360725800ce","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"An improved prognosis for CRC patients was associated with the act... |
QA:120d89486e7c5a20a41a12f7 | QAG:fa1c13e1ed1ee0e51eb3f5e9 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Microsatellite instability in sporadic colon cancer was associated with an improved prognosis at the population level"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:704d5ea54207717dfab18428","quotes":["33. Samowitz WS, et al. Microsatellite instability in sporadic colon cancer ... | [
"CLM:704d5ea54207717dfab18428",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC8262295"
] | [
"SPAN:62eeca2912b45e4648f32c1c"
] | [] | [] | {"qa_id":"QA:120d89486e7c5a20a41a12f7","qa_group_id":"QAG:fa1c13e1ed1ee0e51eb3f5e9","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Microsatellite instability in sporadic colon cancer was associated... |
QA:128977d4c2c5f8da8cc3d02f | QAG:aceb8fe7daf53d75ff323c33 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Here, we firstly presented a retrospective case series of five advanced dMMR/MSI-H CRC patients who achieved good response to CRIT"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact suppo... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e132e57fbe2ba1252da8bd05","quotes":["Here, we firstly presented a retrospective case series of five advanced dMMR... | [
"CLM:e132e57fbe2ba1252da8bd05",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC8714781"
] | [
"SPAN:a8f6194eefb9bcbe25ec15df"
] | [] | [] | {"qa_id":"QA:128977d4c2c5f8da8cc3d02f","qa_group_id":"QAG:aceb8fe7daf53d75ff323c33","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Here, we firstly presented a retrospective case series of five adv... |
QA:15e96f36d130b4dce2c21456 | QAG:95a699e9303b9e159a55b8bf | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Our results also showed that patients with BRAF -mutant CRC who received dual-drug immunotherapy achieved a better ORR than those who received single-drug immunotherapy ( P1 ═ 0.006)"? Return the original wording with paper, Claim, and Evidence Span references.
Integr... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8b88c7fdc41834ba5b26f232","quotes":["Our results also showed that patients with BRAF -mutant CRC who received dua... | [
"CLM:8b88c7fdc41834ba5b26f232",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC10113953"
] | [
"SPAN:b553d7cb74f3360462cb7454"
] | [] | [] | {"qa_id":"QA:15e96f36d130b4dce2c21456","qa_group_id":"QAG:95a699e9303b9e159a55b8bf","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Our results also showed that patients with BRAF -mutant CRC who re... |
QA:1710bb0f3e0edd8ae09c5cf5 | QAG:a85fbdf511528aedf02b3555 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Conclusions Pembrolizumab led to significantly longer progression-free survival than chemotherapy when received as first-line therapy for MSI-H-dMMR metastatic colorectal cancer, with fewer treatment-related adverse events"? Return the original wording with paper, Clai... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e307b484a2c9bb4d91233b22","quotes":["Conclusions Pembrolizumab led to significantly longer progression-free survi... | [
"CLM:e307b484a2c9bb4d91233b22",
"CLM:439debb91a7c2319411d2844"
] | [
"PMID:33264544"
] | [
"SPAN:6a169608d4dbe93a334ae32b"
] | [] | [] | {"qa_id":"QA:1710bb0f3e0edd8ae09c5cf5","qa_group_id":"QAG:a85fbdf511528aedf02b3555","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Conclusions Pembrolizumab led to significantly longer progression-... |
QA:17c03c7209b6b397faeca9de | QAG:9cea0f757a99200c20f18114 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "In the randomized NRG-GI002 trial ( n = 185), induction chemotherapy with 4 months of FOLFOX followed by CRT and 6 cycles of pembrolizumab failed to meet the mean Neoadjuvant Rectal Cancer score, primary endpoint of the study, compared to induction FOLFOX followed by C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:338aa1c30b125a543323d8b8","quotes":["In the randomized NRG-GI002 trial ( n = 185), induction chemotherapy with 4 ... | [
"CLM:338aa1c30b125a543323d8b8",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC9496787"
] | [
"SPAN:339cc279ff190f7113f853d3"
] | [] | [] | {"qa_id":"QA:17c03c7209b6b397faeca9de","qa_group_id":"QAG:9cea0f757a99200c20f18114","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"In the randomized NRG-GI002 trial ( n = 185), induction chemothera... |
QA:19b92ac35ec248abd488c770 | QAG:fb1d9126ad38028847626d46 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "However, it should be noticed that 11% of the patients enrolled had stage IV rectal cancer, and that among the 12 patients achieving a complete response, a proved pCR to CRT plus galunisertib was achieved in only 5 out of 25 patients undergoing surgery (20%), the rest ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b8bec15480c9580aa51c1dd8","quotes":["However, it should be noticed that 11% of the patients enrolled had stage IV... | [
"CLM:b8bec15480c9580aa51c1dd8",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC9496787"
] | [
"SPAN:45c4ceecfc53be872acf05af"
] | [] | [] | {"qa_id":"QA:19b92ac35ec248abd488c770","qa_group_id":"QAG:fb1d9126ad38028847626d46","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"However, it should be noticed that 11% of the patients enrolled ha... |
QA:1a40fe9891d5823d7928bac3 | QAG:7a4159a24cfe3a14fb84b93e | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Background In a portion of patients with DNA mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) rectal cancer, clinical complete response (cCR) could be achieved after anti-programmed cell death protein 1 (anti-PD-1) immunotherapy"? Return the ori... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:5a257d2f8e8b3d85338d05cf","quotes":["Background In a portion of patients with DNA mismatch repair-deficient (dMMR... | [
"CLM:5a257d2f8e8b3d85338d05cf",
"CLM:439debb91a7c2319411d2844"
] | [
"PMID:36030556"
] | [
"SPAN:58f2c6f3cc37e04af653927a"
] | [] | [] | {"qa_id":"QA:1a40fe9891d5823d7928bac3","qa_group_id":"QAG:7a4159a24cfe3a14fb84b93e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Background In a portion of patients with DNA mismatch repair-defic... |
QA:1aa67dfc82a11a841aa9a104 | QAG:871b01ca5aff7cbfd086c549 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "The expression of both CMTM6 and PD-L1 in dMMR CRC was higher than that in pMMR CRC ( P < 0.001, P < 0.001, P < 0.001 and P = 0.002, Supplementary Table 4)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirement... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:63c16f14ed3e0c1308ea590c","quotes":["The expression of both CMTM6 and PD-L1 in dMMR CRC was higher than that in p... | [
"CLM:63c16f14ed3e0c1308ea590c",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC8505364"
] | [
"SPAN:2cf2f30f533287854a6ab9cb"
] | [] | [] | {"qa_id":"QA:1aa67dfc82a11a841aa9a104","qa_group_id":"QAG:871b01ca5aff7cbfd086c549","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"The expression of both CMTM6 and PD-L1 in dMMR CRC was higher than... |
QA:1bb19128a61a248efb253294 | QAG:5b1ccc12e2e98cfa2252b60b | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "In summary, APC mutations was associated with poor outcomes of immunotherapy in CRC patients regardless of MSI status"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a3be8aca8ecc6ab638565879","quotes":["In summary, APC mutations are associated with poor outcomes of immunotherapy... | [
"CLM:a3be8aca8ecc6ab638565879",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC9300385"
] | [
"SPAN:0bf42392e4c8f50b7dff3484"
] | [] | [] | {"qa_id":"QA:1bb19128a61a248efb253294","qa_group_id":"QAG:5b1ccc12e2e98cfa2252b60b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"In summary, APC mutations was associated with poor outcomes of imm... |
QA:1bb85ec75219658e6ea4a83e | QAG:d036910bd8768c61280186eb | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "(4) no patients received anti-PD-1/PD-L1 therapy"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references; assess the embedded... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:52aa13fee60932a4540a7d82","quotes":["The inclusion criteria were as follows: (1) all patients were diagnosed with... | [
"CLM:52aa13fee60932a4540a7d82",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC8505364"
] | [
"SPAN:ac832faed8054015ee2920ef"
] | [] | [] | {"qa_id":"QA:1bb85ec75219658e6ea4a83e","qa_group_id":"QAG:d036910bd8768c61280186eb","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"(4) no patients received anti-PD-1/PD-L1 therapy\"? Return the ori... |
QA:1be3ae5c37ea7d8eb95e2fb5 | QAG:9b3e6e16e32d4a6cea1fdaff | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "It has been showed that ZG16 expression is decreased in CRC patients , and the expression of ZG16 is significantly correlated with overall survival and progression free survival based on The Cancer Genome Atlas (TCGA) COAD dataset (Figure S1)"? Return the original word... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0f32f3c615f366da5eeb00e0","quotes":["It has been showed that ZG16 expression is significantly decreased in CRC pa... | [
"CLM:0f32f3c615f366da5eeb00e0",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC7773682"
] | [
"SPAN:e550d6a5aace2ddf998dc432"
] | [] | [] | {"qa_id":"QA:1be3ae5c37ea7d8eb95e2fb5","qa_group_id":"QAG:9b3e6e16e32d4a6cea1fdaff","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"It has been showed that ZG16 expression is decreased in CRC patien... |
QA:1e31c4bda36eea26514703b6 | QAG:a8c7f508f1e70b6736fc3867 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "In conclusion, our study demonstrated that neoadjuvant anti-PD-1 therapy with or without chemotherapy was associated with promising short-term outcome and acceptable adverse events in advanced MSI-H/dMMR colorectal cancer"? Return the original wording with paper, Claim... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3a39e640e8be9acd2a17720c","quotes":["In conclusion, our study demonstrated that neoadjuvant anti-PD-1 therapy wit... | [
"CLM:3a39e640e8be9acd2a17720c",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC6984585"
] | [
"SPAN:28920594ab1f841e32c91674"
] | [] | [] | {"qa_id":"QA:1e31c4bda36eea26514703b6","qa_group_id":"QAG:a8c7f508f1e70b6736fc3867","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"In conclusion, our study demonstrated that neoadjuvant anti-PD-1 t... |
QA:1e6216c23f29e2bb7fbd9575 | QAG:f40f59bab570d458d5b3e52a | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "It has been showed that ZG16 expression is significantly decreased in CRC patients , and the expression of ZG16 was correlated with overall survival and progression free survival based on The Cancer Genome Atlas (TCGA) COAD dataset (Figure S1)"? Return the original wor... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:fa18e3c1c2c6e6da46dcbcd8","quotes":["It has been showed that ZG16 expression is significantly decreased in CRC pa... | [
"CLM:fa18e3c1c2c6e6da46dcbcd8",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC7773682"
] | [
"SPAN:e550d6a5aace2ddf998dc432"
] | [] | [] | {"qa_id":"QA:1e6216c23f29e2bb7fbd9575","qa_group_id":"QAG:f40f59bab570d458d5b3e52a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"It has been showed that ZG16 expression is significantly decreased... |
QA:1f47f1581dccf6196329469b | QAG:c99d6c523e765b85662cde51 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "In line with our findings, previous analysis of the TCGA database and subsequent IHC analysis showed increased expression of cGAS and STING in MSI-H Stage I–IV CRC"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance req... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8aead1c180639016607a3e0c","quotes":["In line with our findings, previous analysis of the TCGA database and subseq... | [
"CLM:8aead1c180639016607a3e0c",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC9818394"
] | [
"SPAN:fac7b6ea2554c19b9d240f6f"
] | [] | [] | {"qa_id":"QA:1f47f1581dccf6196329469b","qa_group_id":"QAG:c99d6c523e765b85662cde51","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"In line with our findings, previous analysis of the TCGA database ... |
QA:227ddb0595947e12db206e70 | QAG:eb8802e8fed6b6ac21ffc205 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Anti-PD-1 combined with anti-CTLA-4 increased the ORR in patients with MSI-H CRC, thereby reducing the incidence of intrinsic resistance"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c8964168a7834af74a051984","quotes":["Anti-PD-1 combined with anti-CTLA-4 significantly increased the ORR in patie... | [
"CLM:c8964168a7834af74a051984",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC10113953"
] | [
"SPAN:6c2d6fdfd3ed36888fa85152"
] | [] | [] | {"qa_id":"QA:227ddb0595947e12db206e70","qa_group_id":"QAG:eb8802e8fed6b6ac21ffc205","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Anti-PD-1 combined with anti-CTLA-4 increased the ORR in patients ... |
QA:26370acac748deeec0fa8f89 | QAG:0cf0e052ce4a932546c8ea5b | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Previous research reported that PD-L1 was expressed in neoplastic cells (NCs) and tumor-infiltrating immune cells and was associated with dMMR advanced CRC"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirement... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:edccd1e445b6e17f2c74cc0c","quotes":["Previous research reported that PD-L1 was expressed in neoplastic cells (NCs... | [
"CLM:edccd1e445b6e17f2c74cc0c",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC9549670"
] | [
"SPAN:49c204089c3e8f23fa50be99"
] | [] | [] | {"qa_id":"QA:26370acac748deeec0fa8f89","qa_group_id":"QAG:0cf0e052ce4a932546c8ea5b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Previous research reported that PD-L1 was expressed in neoplastic ... |
QA:27721ab6f76e64c2a08ed5bb | QAG:7ef515a1049442c387ac5d4d | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "PBLs, LNLs, and TILs from 21 CRC patients who received surgical resection were examined with flow cytometry as in Figure 1 . ( A ) Representative flow cytometry staining (upper) and summaries (lower) for the frequency of FOXP3 + CD4 + T cell populations in PBLs, LNLs, ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9f5e021df6eee6562eb2064e","quotes":["PBLs, LNLs, and TILs from 21 CRC patients who received surgical resection we... | [
"CLM:9f5e021df6eee6562eb2064e",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC8262295"
] | [
"SPAN:0566a2a9a762842e37f3dd68"
] | [] | [] | {"qa_id":"QA:27721ab6f76e64c2a08ed5bb","qa_group_id":"QAG:7ef515a1049442c387ac5d4d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"PBLs, LNLs, and TILs from 21 CRC patients who received surgical re... |
QA:27f18f3c77a18048f17c08e7 | QAG:c57622bfa21ab49977de2179 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Mouse experiments demonstrated that IL-1β-driven MDSC infiltration inhibited the accumulation of CD8 + T cells, which enhanced the anti-PD-1 resistance of MSI-H/dMMR CRC"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenan... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:608dfe2e6ef0d1b00a3295d5","quotes":["Mouse experiments demonstrated that IL-1β-driven MDSC infiltration suppresse... | [
"CLM:608dfe2e6ef0d1b00a3295d5",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC10142806"
] | [
"SPAN:606d098cc03c967fa91d9d96"
] | [] | [] | {"qa_id":"QA:27f18f3c77a18048f17c08e7","qa_group_id":"QAG:c57622bfa21ab49977de2179","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Mouse experiments demonstrated that IL-1β-driven MDSC infiltration... |
QA:28443c7e6c869938f222f828 | QAG:001a178ab19c328f81e96ac0 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Using multiple cohorts of colorectal cancer, including TCGA data, a microarray dataset ( n = 148), and formalin-fixed, paraffin-embedded samples ( n = 395), we found that the expression of miR-148a-3p was decreased in dMMR/MSI-H tumors, correlating inversely with PD-L1... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:98862cc0bfd3fb19f26c0aa9","quotes":["Using multiple cohorts of colorectal cancer, includ... | [
"CLM:98862cc0bfd3fb19f26c0aa9",
"CLM:439debb91a7c2319411d2844",
"CLM:572fe8772d149aaaee35e012"
] | [
"PMID:30872332",
"PMCID:PMC10772321"
] | [
"SPAN:5e5e7869577be08526b82388",
"SPAN:6324fc4eaeb9fc95a4fb3c86"
] | [
"ASC2:5182bc445e95e13e837ad687"
] | [
"HYP:DCH:e4169ee24ddfaaa7cd5e1d88"
] | {"qa_id":"QA:28443c7e6c869938f222f828","qa_group_id":"QAG:001a178ab19c328f81e96ac0","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Using multiple cohorts of colorectal cancer, including TCGA data, ... |
QA:28551d4e438057528f01bb1e | QAG:0399c0b426aecd01b9405201 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "7%, while that of 24 patients who received second-line immunotherapy was 62.5%"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:92bf2cf944a4e5ac1e14c856","quotes":["In one clinical trial of CRC, the ORR of 41 patients who received third-line... | [
"CLM:92bf2cf944a4e5ac1e14c856",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC10113953"
] | [
"SPAN:cf363a7eca5c9328e5a93004"
] | [] | [] | {"qa_id":"QA:28551d4e438057528f01bb1e","qa_group_id":"QAG:0399c0b426aecd01b9405201","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"7%, while that of 24 patients who received second-line immunothera... |
QA:29c9d2fa8de3e5aa8113f309 | QAG:2b911123db84799b59b43400 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "The current study aims to evaluate the safety and short-term effect of neoadjuvant anti-PD-1 therapy with or without chemotherapy in patients with dMMR/MSI-H locally advanced or metastatic colorectal cancer"? Return the original wording with paper, Claim, and Evidence ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3c8c269971e4077f1acce3f1","quotes":["The current study aims to evaluate the safety and short-term effect of neoad... | [
"CLM:3c8c269971e4077f1acce3f1",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC6984585"
] | [
"SPAN:ee1ec114513fe1af3c6da2cb"
] | [] | [] | {"qa_id":"QA:29c9d2fa8de3e5aa8113f309","qa_group_id":"QAG:2b911123db84799b59b43400","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"The current study aims to evaluate the safety and short-term effec... |
QA:2a5f2d3ea7f0ce4bd03cd1a3 | QAG:7b89191a3e59e03b4f209ce6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Although ICIs have unique efficacy and significant survival benefits for MSI-H CRC patients, our results demonstrated that immunotherapy in patients with MSI-H CRC has not achieved the expected high efficacy"? Return the original wording with paper, Claim, and Evidence... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:24858ec99200084772b084f0","quotes":["Although ICIs have unique efficacy and significant survival benefits for MSI... | [
"CLM:24858ec99200084772b084f0",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC10113953"
] | [
"SPAN:7d6dce06e165b73fd694feed"
] | [] | [] | {"qa_id":"QA:2a5f2d3ea7f0ce4bd03cd1a3","qa_group_id":"QAG:7b89191a3e59e03b4f209ce6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Although ICIs have unique efficacy and significant survival benefi... |
QA:2b06e20ee1da17172d1c0ed1 | QAG:8ee987849a5e94f508604103 | provenance_qa | paper_evidence_availability | provenance_qa | G007 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9281127? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9281127","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9281127"
] | [] | [] | [] | {"qa_id":"QA:2b06e20ee1da17172d1c0ed1","qa_group_id":"QAG:8ee987849a5e94f508604103","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G007","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9281127... |
QA:2c8765df1d7c1c29c01fdbb3 | QAG:74b018f308df6186e09a5c19 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "All responders had dMMR/MSI-H CRC, and no patients with a POLE mutation achieved response"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evid... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:69bd8cc312398f06b97561ae","quotes":["All responders had dMMR/MSI-H CRC, and no patients with a POLE mutation achi... | [
"CLM:69bd8cc312398f06b97561ae",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC7577804"
] | [
"SPAN:d8eb0e72640247067ee18e3b"
] | [] | [] | {"qa_id":"QA:2c8765df1d7c1c29c01fdbb3","qa_group_id":"QAG:74b018f308df6186e09a5c19","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"All responders had dMMR/MSI-H CRC, and no patients with a POLE mut... |
QA:2dd99201845a23a44235a56b | QAG:312e9fffb9de5d30dc5cff6e | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "We performed immunohistochemistry (IHC) analysis and qRT-PCR in a cohort of CRC patients, and found that ZG16 was correlated with lymphatic invasive and distant metastasis"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated proven... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c9ea56fbdf1e1cb1bec17bb1","quotes":["We performed immunohistochemistry (IHC) analysis and qRT-PCR in a cohort of ... | [
"CLM:c9ea56fbdf1e1cb1bec17bb1",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC7773682"
] | [
"SPAN:4500eb9e5164d5f7d42bcd9a"
] | [] | [] | {"qa_id":"QA:2dd99201845a23a44235a56b","qa_group_id":"QAG:312e9fffb9de5d30dc5cff6e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"We performed immunohistochemistry (IHC) analysis and qRT-PCR in a ... |
QA:30c07ba1cd9905b0b88bbb1e | QAG:202cacdad47179a19c25beba | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "A survey among pathologists from Australia, conducted to assess Lynch syndrome tumor screening practices, reported that from 36 laboratories that received CRC specimens, only 47% reported following a universal testing approach, 30% performed the test only for “red flag... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3c71350dd72ccc4293f5f97b","quotes":["A survey among pathologists from Australia, conducted to assess Lynch syndro... | [
"CLM:3c71350dd72ccc4293f5f97b",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC10981578"
] | [
"SPAN:799bd44e26e2b4986d61b58d"
] | [] | [] | {"qa_id":"QA:30c07ba1cd9905b0b88bbb1e","qa_group_id":"QAG:202cacdad47179a19c25beba","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"A survey among pathologists from Australia, conducted to assess Ly... |
QA:361af45754edb93e0cf826c8 | QAG:2f932dda7e5660c10364e5f4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "In terms of Crohn-like lymphoid aggregates, a previous study showed that the formation of ectopic lymphoid tissues was correlated with better CRC survival outcomes, although none of the patients had received treatment with ICIs"? Return the original wording with paper,... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:216723ca7a711aa963fc199d","quotes":["In terms of Crohn-like lymphoid aggregates, a previous study showed that the... | [
"CLM:216723ca7a711aa963fc199d",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC9582482"
] | [
"SPAN:fb0d2876781361c7b8fcead8"
] | [] | [] | {"qa_id":"QA:361af45754edb93e0cf826c8","qa_group_id":"QAG:2f932dda7e5660c10364e5f4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"In terms of Crohn-like lymphoid aggregates, a previous study showe... |
QA:361b4fa2d20c1e6d316a2fe8 | QAG:c6121e527f0f23d7d5151ebe | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Considering that ZG16 expression was dramatically decreased in tumor area compared to adjacent normal tissue and ZG16 contains a lection domain, we hypothesized that ZG16 may function as a new immune response regulator in colorectal cancer and a potential biomarker for... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6ce03ad4ae3b4fe22c09eefb","quotes":["Considering that ZG16 expression was dramatically decreased in tumor area co... | [
"CLM:6ce03ad4ae3b4fe22c09eefb",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC7773682"
] | [
"SPAN:d59ee70fd396a6e0fe096067"
] | [] | [] | {"qa_id":"QA:361b4fa2d20c1e6d316a2fe8","qa_group_id":"QAG:c6121e527f0f23d7d5151ebe","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Considering that ZG16 expression was dramatically decreased in tum... |
QA:393b5164c8db774963639dff | QAG:7a4965cec97d0f079dc588c9 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "NGS revealed hypermutated phenotype CRC in only one patient with a P286C mutation, but the other sites (R559W and G1086S) was not associated with high tumor mutation burden (TMB) in each different NGS panel ( S1 Table )"? Return the original wording with paper, Claim, ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9889bab1a166fb8e474aac90","quotes":["NGS revealed hypermutated phenotype CRC in only one patient with a P286C mut... | [
"CLM:9889bab1a166fb8e474aac90",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC7577804"
] | [
"SPAN:873e75e5579288d40a4990ac"
] | [] | [] | {"qa_id":"QA:393b5164c8db774963639dff","qa_group_id":"QAG:7a4965cec97d0f079dc588c9","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"NGS revealed hypermutated phenotype CRC in only one patient with a... |
QA:3c5f25f8dafca15fdc303656 | QAG:37b7b3820a147503ee91e42a | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "In addition, patients with pStage 0–III MSI-H CRC who received surgical resection at SCC between 1999 and 2015 were enrolled in the prognostic analysis as the MSI-H cohort (SCC cohort)"? Return the original wording with paper, Claim, and Evidence Span references.
Inte... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d45781dbf78ca3896e241e02","quotes":["In addition, patients with pStage 0–III MSI-H CRC who received surgical rese... | [
"CLM:d45781dbf78ca3896e241e02",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC8262295"
] | [
"SPAN:b82e3006badbf5a020678453"
] | [] | [] | {"qa_id":"QA:3c5f25f8dafca15fdc303656","qa_group_id":"QAG:37b7b3820a147503ee91e42a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"In addition, patients with pStage 0–III MSI-H CRC who received sur... |
QA:3d5d3c2bd3fd7f2afb028416 | QAG:f8be51b7c8cde316155439b6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Because some guidelines have recommended examination of a minimum of 12 LNs ( 13 , 14 ), only 21 CRC patients in the cohort received LN dissection with less than 12, and the number of LNs dissected in patients with pN1–2 was comparable with that in patients with pN0, s... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c0cb6c8a86644f759221c0e4","quotes":["Because some guidelines have recommended examination of a minimum of 12 LNs ... | [
"CLM:c0cb6c8a86644f759221c0e4",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC8262295"
] | [
"SPAN:f99631d15f5231191b35b03e"
] | [] | [] | {"qa_id":"QA:3d5d3c2bd3fd7f2afb028416","qa_group_id":"QAG:f8be51b7c8cde316155439b6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Because some guidelines have recommended examination of a minimum ... |
QA:406f79c8e3b7b89038b07cae | QAG:d7afae187be96d9f1d2f0d19 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "121 cases of dMMR and 127 cases pMMR were used for statistical analysis Samples from a total of 32 patients with metastatic/refractory CRC who received PD-1/PD-L1 inhibitor immunotherapy were harvested at Nanfang Hospital, Zhujiang Hospital, Southern Medical University... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b56cdb93f0dc776af48f34e9","quotes":["121 cases of dMMR and 127 cases pMMR were used for statistical analysis Samp... | [
"CLM:b56cdb93f0dc776af48f34e9",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC8505364"
] | [
"SPAN:c208e34d8aabd438e6fbe595"
] | [] | [] | {"qa_id":"QA:406f79c8e3b7b89038b07cae","qa_group_id":"QAG:d7afae187be96d9f1d2f0d19","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"121 cases of dMMR and 127 cases pMMR were used for statistical ana... |
QA:461eeb3f5d454941c37e129b | QAG:8de1b16e7c231f9b1ea6ee4d | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "ZG16 gene expression and copy number variations (CNV) was associated with multiple molecular and clinicopathological features of CRC including MSI, MLH1 silencing and so on"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated prove... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0995e89bbb1227701c4fcd3a","quotes":["ZG16 gene expression and copy number variations (CNV) were associated with m... | [
"CLM:0995e89bbb1227701c4fcd3a",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC7773682"
] | [
"SPAN:35a76a33ccff79519b9dc7c9"
] | [] | [] | {"qa_id":"QA:461eeb3f5d454941c37e129b","qa_group_id":"QAG:8de1b16e7c231f9b1ea6ee4d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"ZG16 gene expression and copy number variations (CNV) was associat... |
QA:46286cd7ef86b8eda2a60d7e | QAG:0d9c4ee69dd97f8d07c96e27 | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "Among them, dMMR/MSI⁃H metastatic CRC (mCRC) accounted for only 4%, while the proportion of dMMR/MSI⁃H LACRC increased to 12% ~ 20% ( 4 )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exac... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3376d6254971f03586350904","quotes":["Among them, dMMR/MSI⁃H metastatic CRC (mCRC) accounted for only 4%, while th... | [
"CLM:3376d6254971f03586350904",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC9359076"
] | [
"SPAN:ca19b5a8d1a3b243f2c6dd24"
] | [] | [] | {"qa_id":"QA:46286cd7ef86b8eda2a60d7e","qa_group_id":"QAG:0d9c4ee69dd97f8d07c96e27","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"Among them, dMMR/MSI⁃H metastatic CRC (mCRC) accounted for only 4%... |
QA:46a698394ec7409cad4a9203 | QAG:f4f1c951567309f5d5a5034f | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "These findings suggest that the frequency of eTregs in LNLs is detected at an intermediate level between that of PBLs and TILs and that FOXP3 lo non-Tregs may be promoted by inflammation caused by Fusobacteria — not only in TILs, but also in LNLs"? Return the original ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7b3e540a0c3612e50808ade6","quotes":["These findings suggest that the frequency of eTregs in LNLs is detected at a... | [
"CLM:7b3e540a0c3612e50808ade6",
"CLM:348c7a61fb91d919ec827c93"
] | [
"PMCID:PMC8262295"
] | [
"SPAN:c5cd97f348b32e474d1a7076",
"SPAN:d5215380c778a89f012d2c9c"
] | [] | [] | {"qa_id":"QA:46a698394ec7409cad4a9203","qa_group_id":"QAG:f4f1c951567309f5d5a5034f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"These findings suggest that the frequency of eTregs in LNLs is det... |
QA:48ebb8591249b7dd611c538f | QAG:2dfa870d7957070c112c447e | provenance_qa | exact_evidence_retrieval | provenance_qa | G007 | en | train | Which exact source passage supports the statement "This study aims to evaluate the efficacy and safety of avelumab in patients with previously treated CRC with deficient MMR/MSI-H as well as those with POLE mutations"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1a05152f16a2d9f768a2ceef","quotes":["This study aimed to evaluate the efficacy and safety of avelumab in patients... | [
"CLM:1a05152f16a2d9f768a2ceef",
"CLM:439debb91a7c2319411d2844"
] | [
"PMCID:PMC7577804"
] | [
"SPAN:f686104b20fc960f084d23c3"
] | [] | [] | {"qa_id":"QA:48ebb8591249b7dd611c538f","qa_group_id":"QAG:2dfa870d7957070c112c447e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G007","question":"Which exact source passage supports the statement \"This study aims to evaluate the efficacy and safety of avelumab in... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.